Epistem in £4.3m placing

MANCHESTER diagnostics firm Epistem is to raise £4.3m to support the commercial launch of its main product, the Genedrive.

The AIM-listed business is placing 793,398 ordinary shares with new and existing investors at £5.45 a share, a 4% discount to the closing price of £5.67 on December 6.

Epistem's Genedrive is a machine which uses molecular diagnosis to provide a rapid test which can highlight a range of conditions within 30 minutes.

It plans to use the cash to support the use of the device for... For the full story register now for free or login below...